Company Transfers Tianjin Peak Shares

Release time:


On May 28, Jianfeng Group held the 16th meeting of the eighth board of directors, which deliberated and passed the proposal on the sale of Tianjin Jianfeng equity.
The meeting agreed to sign a binding framework agreement between Jianfeng Pharmaceutical and France's Diana Naturals SAS Company to sell 54.5% equity of Tianjin Jianfeng Natural Products Research and Development Co., Ltd. to Diana Naturals SAS (or its designated buyer) at a price of 63.22 million yuan (RMB).
The agreement signed this time is only a binding framework agreement. The two parties will further negotiate and negotiate, and implement it after reaching a formal equity transfer agreement and approval by relevant government departments.